The use of pan-cancer analysis of ADAMTS9 expression in various cancer types

Related Experiment Video

Updated: Nov 19, 2025

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.9K

Shijun Jiang1,2, Ying Jiang1, Yingli Cao3

  • 1Department of Biochemistry & Molecular Biology, Mudanjiang Medical University, Mudanjiang, Heilongjiang 157011, PR China.

Epigenomics
|January 27, 2021
PubMed
Abstract

No abstract available in PubMed .

Keywords:
ADAMTS9angiogenesiscancerexpressionextracellular matrixpromoter hypermethylation

More Related Videos

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions
09:00

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions

Published on: April 18, 2025

1.0K
Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

7.0K

Related Experiment Videos

Last Updated: Nov 19, 2025

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.9K
A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions
09:00

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions

Published on: April 18, 2025

1.0K
Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

7.0K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.1K

Articles linked to this work by shared authors, journal, and citation graph.

LncRNA AC245100.4 binds HSP90 to promote the proliferation of prostate cancer.

Epigenomics·2020

miR-124-3p availability is antagonized by LncRNA-MALAT1 for Slug-induced tumor metastasis in hepatocellular carcinoma.

Cancer medicine·2019

Identification of competitive endogenous RNAs network in breast cancer.

Cancer medicine·2019

[Effects of Pa-pex 11 gene on penicillin production in Penicillium aurantiogriseum].

Wei sheng wu xue bao = Acta microbiologica Sinica·2010

Inhibition of lung fluid clearance and epithelial Na+ channels by chlorine, hypochlorous acid, and chloramines.

The Journal of biological chemistry·2010

Discovery and optimization of novel 3-piperazinylcoumarin antagonist of chemokine-like factor 1 with oral antiasthma activity in mice.

Journal of medicinal chemistry·2010

From discovery to clinical implementation: a bibliometric analysis of DNA methylation biomarkers in non-small cell lung cancer, 1999-2025.

Epigenomics·2026

Evaluation of mRNA expression and DNA methylation status of immune checkpoints in the peripheral blood of COVID-19 patients.

Epigenomics·2026

Association of Xeroderma Pigmentosum group F (XPF) with epigenetic regulation of T helper cell differentiation in coronary artery disease-associated prostate cancer.

Epigenomics·2026

Cross-cohort DNA methylation analysis shows CpG island promoter hypermethylation features associated with cervical lesion grade.

Epigenomics·2026

ATP1A2 as a subtype-associated candidate prognostic biomarker in breast cancer: an integrated transcriptomic, epigenetic and in vitro analysis.

Epigenomics·2026

Cell-free DNA fragmentomics: from chromatin biology to clinical stratification.

Epigenomics·2026

Predicting recurrence risk after neoadjuvant therapy in breast cancer: a single-center retrospective cohort study integrating residual cancer burden and immune microenvironment features.

Frontiers in oncology·2026

Prognostic associations of PD-L1 expression and BAP1 loss in pleural mesothelioma: a retrospective single-center cohort from Colombia.

Frontiers in oncology·2026

Multiparametric MRI radiomics for preoperative prediction of tumor budding grade in rectal cancer.

Frontiers in oncology·2026

IVIM-based habitat imaging for non-invasive assessment of Ki-67 proliferation status in cervical cancer.

Frontiers in oncology·2026

Diagnostic performance of next-generation sequencing in thyroid nodules and molecular correlates of tumor aggressiveness in papillary thyroid carcinoma.

Frontiers in endocrinology·2026

Multimodal radiomics based on dynamic contrast-enhanced ultrasound for predicting cervical lymph node metastasis in papillary thyroid carcinoma with Hashimoto's thyroiditis.

Frontiers in oncology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us